The Sabin-Feldman dye test
is a serological test used to detect antibodies against Toxoplasma gondii, the parasite that causes toxoplasmosis. It was one of the original tests for toxoplasmosis and is still considered a reference test in some laboratories, although it is less commonly used today due to its complexity and the need for live parasites.
Here's an overview of the Sabin-Feldman dye test procedure:
Principle:
The test is based on the principle that viable Toxoplasma tachyzoites (the rapidly multiplying form of the parasite) can take up a dye (methylene blue) in the absence of specific antibodies. However, if specific antibodies are present in the patient's serum, they will interact with the tachyzoites, causing them to become "neutralized" and unable to take up the dye.
Materials:
• Live Toxoplasma tachyzoites: This is the most critical and challenging aspect of the test, as it requires a source of viable parasites. They are typically maintained in cell culture.
• Methylene blue dye: A dye that is taken up by viable tachyzoites.
• Test serum: The patient's serum, which is serially diluted.
• Complement: Fresh, unheated serum from a source that provides complement (e.g., normal human serum or rabbit serum). Complement is required for the antibody-mediated neutralization of the tachyzoites.
• Microscope slides and coverslips: For viewing the tachyzoites.
• Microscope: A light microscope for examining the slides.
• Diluent: Phosphate-buffered saline (PBS) or a similar buffer.
Procedure:
1. Tachyzoite Preparation:
• Harvest live Toxoplasma tachyzoites from cell culture.
• Wash the tachyzoites to remove cell debris.
• Adjust the concentration of tachyzoites to the desired level (typically around 10^6 tachyzoites/mL).
2. Serum Dilutions:
• Prepare serial dilutions of the patient's serum in the diluent (e.g., 1:16, 1:64, 1:256, etc.).
• Include a positive control (serum known to contain Toxoplasma antibodies) and a negative control (serum known to be antibody-free).
3. Test Mixture:
• Mix equal volumes of the diluted serum, the Toxoplasma tachyzoite suspension, and the complement source.
• Incubate the mixture at 37°C for 1 hour to allow the antibody-complement interaction to occur.
4. Dye Addition:
• Add methylene blue dye to each mixture.
• Incubate for a few minutes.
5. Slide Preparation:
• Place a drop of each mixture onto a microscope slide.
• Cover with a coverslip.
6. Microscopic Examination:
• Examine the slides under a light microscope at a magnification of 400x or higher.
• Count the number of stained (blue) and unstained (clear) tachyzoites in each field of view.
• Examine at least 100 tachyzoites per slide.
Interpretation:
• Positive Result: If the serum contains Toxoplasma antibodies, the tachyzoites will be neutralized and will not take up the methylene blue dye. Therefore, a positive result is indicated by a high percentage of unstained (clear) tachyzoites. A titer is determined as the highest dilution of serum that results in at least 50% unstained tachyzoites.
• Negative Result: If the serum does not contain Toxoplasma antibodies, the tachyzoites will remain viable and will take up the methylene blue dye. Therefore, a negative result is indicated by a high percentage of stained (blue) tachyzoites.
Quality Control:
• Positive Control: Should show a high percentage of unstained tachyzoites.
• Negative Control: Should show a high percentage of stained tachyzoites.
• Complement Control: A control mixture containing tachyzoites and complement, but no serum, should show a high percentage of stained tachyzoites. This ensures that the complement is not toxic to the tachyzoites.
• Tachyzoite Viability: The tachyzoites should be actively motile and of good quality.
Limitations
• Subjective Interpretation: The interpretation of the results is somewhat subjective and depends on the experience of the observer.
https://t.me/Laboratorypractice
is a serological test used to detect antibodies against Toxoplasma gondii, the parasite that causes toxoplasmosis. It was one of the original tests for toxoplasmosis and is still considered a reference test in some laboratories, although it is less commonly used today due to its complexity and the need for live parasites.
Here's an overview of the Sabin-Feldman dye test procedure:
Principle:
The test is based on the principle that viable Toxoplasma tachyzoites (the rapidly multiplying form of the parasite) can take up a dye (methylene blue) in the absence of specific antibodies. However, if specific antibodies are present in the patient's serum, they will interact with the tachyzoites, causing them to become "neutralized" and unable to take up the dye.
Materials:
• Live Toxoplasma tachyzoites: This is the most critical and challenging aspect of the test, as it requires a source of viable parasites. They are typically maintained in cell culture.
• Methylene blue dye: A dye that is taken up by viable tachyzoites.
• Test serum: The patient's serum, which is serially diluted.
• Complement: Fresh, unheated serum from a source that provides complement (e.g., normal human serum or rabbit serum). Complement is required for the antibody-mediated neutralization of the tachyzoites.
• Microscope slides and coverslips: For viewing the tachyzoites.
• Microscope: A light microscope for examining the slides.
• Diluent: Phosphate-buffered saline (PBS) or a similar buffer.
Procedure:
1. Tachyzoite Preparation:
• Harvest live Toxoplasma tachyzoites from cell culture.
• Wash the tachyzoites to remove cell debris.
• Adjust the concentration of tachyzoites to the desired level (typically around 10^6 tachyzoites/mL).
2. Serum Dilutions:
• Prepare serial dilutions of the patient's serum in the diluent (e.g., 1:16, 1:64, 1:256, etc.).
• Include a positive control (serum known to contain Toxoplasma antibodies) and a negative control (serum known to be antibody-free).
3. Test Mixture:
• Mix equal volumes of the diluted serum, the Toxoplasma tachyzoite suspension, and the complement source.
• Incubate the mixture at 37°C for 1 hour to allow the antibody-complement interaction to occur.
4. Dye Addition:
• Add methylene blue dye to each mixture.
• Incubate for a few minutes.
5. Slide Preparation:
• Place a drop of each mixture onto a microscope slide.
• Cover with a coverslip.
6. Microscopic Examination:
• Examine the slides under a light microscope at a magnification of 400x or higher.
• Count the number of stained (blue) and unstained (clear) tachyzoites in each field of view.
• Examine at least 100 tachyzoites per slide.
Interpretation:
• Positive Result: If the serum contains Toxoplasma antibodies, the tachyzoites will be neutralized and will not take up the methylene blue dye. Therefore, a positive result is indicated by a high percentage of unstained (clear) tachyzoites. A titer is determined as the highest dilution of serum that results in at least 50% unstained tachyzoites.
• Negative Result: If the serum does not contain Toxoplasma antibodies, the tachyzoites will remain viable and will take up the methylene blue dye. Therefore, a negative result is indicated by a high percentage of stained (blue) tachyzoites.
Quality Control:
• Positive Control: Should show a high percentage of unstained tachyzoites.
• Negative Control: Should show a high percentage of stained tachyzoites.
• Complement Control: A control mixture containing tachyzoites and complement, but no serum, should show a high percentage of stained tachyzoites. This ensures that the complement is not toxic to the tachyzoites.
• Tachyzoite Viability: The tachyzoites should be actively motile and of good quality.
Limitations
• Subjective Interpretation: The interpretation of the results is somewhat subjective and depends on the experience of the observer.
https://t.me/Laboratorypractice
👍4❤2☃1
✍️ Weil-Felix test‼️
The Weil-Felix test is a serological test historically used to diagnose rickettsial infections. However, it's important to note that the Weil-Felix test is now largely outdated and has been replaced by more sensitive and specific diagnostic methods like immunofluorescence assays (IFA) and PCR. It's rarely used in modern clinical practice because of its limitations.
Despite its decline in use, understanding the Weil-Felix test procedure can be helpful for historical context and understanding the evolution of diagnostic techniques. Here's a breakdown of the procedure:
Principle:
The Weil-Felix test relies on the cross-reactivity of antibodies produced during rickettsial infections with certain strains of *Proteus* bacteria (specifically *Proteus vulgaris* and *Proteus mirabilis*). Patients infected with *Rickettsia* produce antibodies that happen to also react with antigens on the surface of these *Proteus* bacteria, causing them to agglutinate (clump together).
Materials:
• Patient serum: The sample to be tested for rickettsial antibodies.
• *Proteus* antigens: Killed and standardized suspensions of *Proteus vulgaris* strains OX2 and OX19, and *Proteus mirabilis* strain OXK. These antigens are commercially available.
• Positive and negative control sera: Sera known to contain or lack rickettsial antibodies, respectively.
• Saline solution: For diluting the serum and antigens.
• Agglutination slides or tiles: For performing the test.
• Droppers or pipettes: For dispensing the serum and antigens.
• Incubator: For maintaining a consistent temperature during incubation (optional).
• Rocker or rotator: To gently mix the reactants (optional).
Procedure:
1. Serum Preparation:
* Prepare serial dilutions of the patient's serum in saline solution. Common dilutions include 1:20, 1:40, 1:80, 1:160, and higher.
2. Test Setup:
* On a clean agglutination slide or tile, place one drop of each *Proteus* antigen suspension (OX2, OX19, and OXK) in separate areas.
* Add one drop of each serum dilution next to each antigen drop.
* Include positive and negative control sera alongside the patient samples.
3. Mixing and Incubation:
* Mix the serum dilution and antigen suspension thoroughly using a clean applicator stick or by gently rocking the slide.
* Incubate the slides at room temperature (or in an incubator at 37°C) for a specified time, typically 1-4 minutes. A longer incubation time might be used, depending on the specific protocol. Gentle rocking or rotation during incubation can improve the sensitivity of the test.
4. Reading the Results:
* Observe the slides for agglutination (clumping) of the *Proteus* bacteria. Agglutination indicates a positive reaction, meaning that the patient's serum contains antibodies that cross-react with the *Proteus* antigens.
* Determine the highest serum dilution that shows visible agglutination. This is the titer.
Interpretation:
• Positive Result: Agglutination observed at a titer of 1:80 or higher is generally considered positive. However, the interpretation of titers can vary depending on the laboratory and the prevalence of rickettsial diseases in the region.
• Negative Result: No agglutination or agglutination at a low titer (e.g., < 1:20) is generally considered negative.
• Differential Diagnosis:
* Different rickettsial diseases are associated with agglutination to different *Proteus* antigens. However, the pattern of reactivity is not always reliable and should not be used as the sole basis for diagnosis. Here's a general guideline:
* OX19: Typhus group (e.g., epidemic typhus, murine typhus)
* OX2: Spotted fever group (e.g., Rocky Mountain spotted fever, boutonneuse fever)
* OXK: Scrub typhus
The Weil-Felix test is a serological test historically used to diagnose rickettsial infections. However, it's important to note that the Weil-Felix test is now largely outdated and has been replaced by more sensitive and specific diagnostic methods like immunofluorescence assays (IFA) and PCR. It's rarely used in modern clinical practice because of its limitations.
Despite its decline in use, understanding the Weil-Felix test procedure can be helpful for historical context and understanding the evolution of diagnostic techniques. Here's a breakdown of the procedure:
Principle:
The Weil-Felix test relies on the cross-reactivity of antibodies produced during rickettsial infections with certain strains of *Proteus* bacteria (specifically *Proteus vulgaris* and *Proteus mirabilis*). Patients infected with *Rickettsia* produce antibodies that happen to also react with antigens on the surface of these *Proteus* bacteria, causing them to agglutinate (clump together).
Materials:
• Patient serum: The sample to be tested for rickettsial antibodies.
• *Proteus* antigens: Killed and standardized suspensions of *Proteus vulgaris* strains OX2 and OX19, and *Proteus mirabilis* strain OXK. These antigens are commercially available.
• Positive and negative control sera: Sera known to contain or lack rickettsial antibodies, respectively.
• Saline solution: For diluting the serum and antigens.
• Agglutination slides or tiles: For performing the test.
• Droppers or pipettes: For dispensing the serum and antigens.
• Incubator: For maintaining a consistent temperature during incubation (optional).
• Rocker or rotator: To gently mix the reactants (optional).
Procedure:
1. Serum Preparation:
* Prepare serial dilutions of the patient's serum in saline solution. Common dilutions include 1:20, 1:40, 1:80, 1:160, and higher.
2. Test Setup:
* On a clean agglutination slide or tile, place one drop of each *Proteus* antigen suspension (OX2, OX19, and OXK) in separate areas.
* Add one drop of each serum dilution next to each antigen drop.
* Include positive and negative control sera alongside the patient samples.
3. Mixing and Incubation:
* Mix the serum dilution and antigen suspension thoroughly using a clean applicator stick or by gently rocking the slide.
* Incubate the slides at room temperature (or in an incubator at 37°C) for a specified time, typically 1-4 minutes. A longer incubation time might be used, depending on the specific protocol. Gentle rocking or rotation during incubation can improve the sensitivity of the test.
4. Reading the Results:
* Observe the slides for agglutination (clumping) of the *Proteus* bacteria. Agglutination indicates a positive reaction, meaning that the patient's serum contains antibodies that cross-react with the *Proteus* antigens.
* Determine the highest serum dilution that shows visible agglutination. This is the titer.
Interpretation:
• Positive Result: Agglutination observed at a titer of 1:80 or higher is generally considered positive. However, the interpretation of titers can vary depending on the laboratory and the prevalence of rickettsial diseases in the region.
• Negative Result: No agglutination or agglutination at a low titer (e.g., < 1:20) is generally considered negative.
• Differential Diagnosis:
* Different rickettsial diseases are associated with agglutination to different *Proteus* antigens. However, the pattern of reactivity is not always reliable and should not be used as the sole basis for diagnosis. Here's a general guideline:
* OX19: Typhus group (e.g., epidemic typhus, murine typhus)
* OX2: Spotted fever group (e.g., Rocky Mountain spotted fever, boutonneuse fever)
* OXK: Scrub typhus
❤2👍1
Test : Helicobacter pylori Test
Indications : The H.pylori test is ordered for following reasons:
• If you currently have a stomach / duodenal ulcer /dyspepsia
• If you had stomach / duodenal ulcer in the past and it has remained untested
• If you have a condition called gastric MALT lymphoma
• Analysis after treatment for H.pylori.
There are several methods to test for H pylori infection.
1. Breath Test
This test is also known as the Carbon Isotope-urea Breath Test (UBT).You are required to stop taking antibiotics and bismuth medicines two weeks prior to the test.
The test is initiated by making you swallow a urea- containing substance. If pylori is present in your gut, the urea you have ingested is broken down into carbon -di -oxide which can be detected in your breath approximately 10 minutes after ingestion.
This is an efficient test to detect the presence of H.pylori. The test is also employed to evaluate anti- pylori treatment.
2. Blood Tests
Blood tests can be carried out to detect the presence of antibodies that may be raised against H.pylori. It does not help much in identifying current H.pylori infections as the test would be positive months after the infection is cured.
3. Stool Test
A stool test is a culture that is done using a stool sample to detect the presence of H.pylori. The test is useful is confirming a present infection.
4. Biopsy
A biopsy tissue sample from the stomach lining is procured through endoscopy. This sample is then processed and examined under the microscope. A biopsy is an accurate procedure to detect H.pylori. It is usually done as a part of a diagnostic procedure for inflammations, ulcers and cancer and is carried out in hospitals.
Physiology : H.pylori is a gram-negative, micro aerophilic bacteria that cause chronic gastritis, or inflammation of the stomach and duodenal ulcers. Of late, it has also been linked to gastric cancers. However, in majority of people H.pylori is present without causing symptoms or complications.
The H.pylori test is mostly done to detect the presence of Helicobacter pylori in a person with symptoms of chronic gastritis.
Normal Range : Negative for urease activity, negative culture, biopsy negative for gastritis and negative for H. pylori.
Interpretation : Normal
No sign of an H pylori infection.
Abnormal
The presence of H.pylori can be detected when any of the above tests are done. This will have to be followed up with appropriate treatment with antibiotics.
Sample : Gastric mucosal biopsy
https://t.me/Laboratorypractice
Indications : The H.pylori test is ordered for following reasons:
• If you currently have a stomach / duodenal ulcer /dyspepsia
• If you had stomach / duodenal ulcer in the past and it has remained untested
• If you have a condition called gastric MALT lymphoma
• Analysis after treatment for H.pylori.
There are several methods to test for H pylori infection.
1. Breath Test
This test is also known as the Carbon Isotope-urea Breath Test (UBT).You are required to stop taking antibiotics and bismuth medicines two weeks prior to the test.
The test is initiated by making you swallow a urea- containing substance. If pylori is present in your gut, the urea you have ingested is broken down into carbon -di -oxide which can be detected in your breath approximately 10 minutes after ingestion.
This is an efficient test to detect the presence of H.pylori. The test is also employed to evaluate anti- pylori treatment.
2. Blood Tests
Blood tests can be carried out to detect the presence of antibodies that may be raised against H.pylori. It does not help much in identifying current H.pylori infections as the test would be positive months after the infection is cured.
3. Stool Test
A stool test is a culture that is done using a stool sample to detect the presence of H.pylori. The test is useful is confirming a present infection.
4. Biopsy
A biopsy tissue sample from the stomach lining is procured through endoscopy. This sample is then processed and examined under the microscope. A biopsy is an accurate procedure to detect H.pylori. It is usually done as a part of a diagnostic procedure for inflammations, ulcers and cancer and is carried out in hospitals.
Physiology : H.pylori is a gram-negative, micro aerophilic bacteria that cause chronic gastritis, or inflammation of the stomach and duodenal ulcers. Of late, it has also been linked to gastric cancers. However, in majority of people H.pylori is present without causing symptoms or complications.
The H.pylori test is mostly done to detect the presence of Helicobacter pylori in a person with symptoms of chronic gastritis.
Normal Range : Negative for urease activity, negative culture, biopsy negative for gastritis and negative for H. pylori.
Interpretation : Normal
No sign of an H pylori infection.
Abnormal
The presence of H.pylori can be detected when any of the above tests are done. This will have to be followed up with appropriate treatment with antibiotics.
Sample : Gastric mucosal biopsy
https://t.me/Laboratorypractice
👍1
Test : Neisseria gonorrhoeae culture
Indications : N gonorrhoeae culture is ordered when gonorrhea is suspected.
N gonorrhoeae is a very fragile organism and mixes easily with the normal human flora. Therefore it must be cultured carefully, using appropriate media (chocolate agar with antibiotics) under laboratory conditions.
Samples include vaginal discharge, pus, swab of genital lesions, discharge or scrapings of the urethra and the endocervix.
In women, cervical swabs are preferred over vaginal or urethral specimens. Throat swab or rectal swabs may be taken from men, but after understanding their sexual practices only.
Swabs may be streaked directly onto petriplates containing culture media or it can be transported to the lab in a vial containing transport medium.
Physiology : Neisseria gonorrhoeae culture test is done to detect the presence of the gram –negative, coffee bean - shaped bacterium, Neisseria gonorrhoeae.
N. gonorrhoeae is a bacterium that causes a sexually-transmitted disease, gonorrhea, which chiefly affects the mucous membranes of the urethra and cervix. Gonorrhea is also known to affect the mucus lining of the rectum, oropharynx, and conjunctivae, although less frequently.
In women, the infection can spread and cause pelvic inflammatory disease (PID).
Normal Range : No Neisseria gonorrhoeae isolated.
Interpretation : Normal
Neisseria gonorrhoeae culture results are negative (no growth)
Abnormal
Neisseria gonorrhoeae culture results are positive. Colonies of the bacteria appear on the culture plates one or two days after incubation with carbon dioxide, at 35 degrees.
A positive result indicates gonorrhea infection for which treatment must be initiated as quickly as possible.
Sample : Body fluid, discharge, pus, swab of genital lesions, urethral discharge, endocervix, throat swab, rectal swab.
Test Method : Culture on selective media. DNA probes, Monoclonal antibodies, Enzyme immunoassay.
Related Tests : Penicillinase Test, RPR, VDRL, Neisseria gonorrhoeae smear
https://t.me/Laboratorypractice
Indications : N gonorrhoeae culture is ordered when gonorrhea is suspected.
N gonorrhoeae is a very fragile organism and mixes easily with the normal human flora. Therefore it must be cultured carefully, using appropriate media (chocolate agar with antibiotics) under laboratory conditions.
Samples include vaginal discharge, pus, swab of genital lesions, discharge or scrapings of the urethra and the endocervix.
In women, cervical swabs are preferred over vaginal or urethral specimens. Throat swab or rectal swabs may be taken from men, but after understanding their sexual practices only.
Swabs may be streaked directly onto petriplates containing culture media or it can be transported to the lab in a vial containing transport medium.
Physiology : Neisseria gonorrhoeae culture test is done to detect the presence of the gram –negative, coffee bean - shaped bacterium, Neisseria gonorrhoeae.
N. gonorrhoeae is a bacterium that causes a sexually-transmitted disease, gonorrhea, which chiefly affects the mucous membranes of the urethra and cervix. Gonorrhea is also known to affect the mucus lining of the rectum, oropharynx, and conjunctivae, although less frequently.
In women, the infection can spread and cause pelvic inflammatory disease (PID).
Normal Range : No Neisseria gonorrhoeae isolated.
Interpretation : Normal
Neisseria gonorrhoeae culture results are negative (no growth)
Abnormal
Neisseria gonorrhoeae culture results are positive. Colonies of the bacteria appear on the culture plates one or two days after incubation with carbon dioxide, at 35 degrees.
A positive result indicates gonorrhea infection for which treatment must be initiated as quickly as possible.
Sample : Body fluid, discharge, pus, swab of genital lesions, urethral discharge, endocervix, throat swab, rectal swab.
Test Method : Culture on selective media. DNA probes, Monoclonal antibodies, Enzyme immunoassay.
Related Tests : Penicillinase Test, RPR, VDRL, Neisseria gonorrhoeae smear
https://t.me/Laboratorypractice
❤1
Urine Analysis Exam.pdf
433.5 KB
Urine analysis ppt and exam
https://t.me/Laboratorypractice
https://t.me/Laboratorypractice
👍1